PUBLICATIONS 2021
Publications of the IRCCS G.B. Bietti Foundation for the Study and Research in Ophthalmology ONLUS.
For more information, please write to:
1) Accuracy of optical coherence tomography for diagnosing glaucoma: an overview of systematic reviews
Michelessi M, Li T, Miele A, Azuara-Blanco A, Qureshi R, Virgili G.
Br J Ophthalmol. 2021 Apr;105(4):490-495.doi: 10.1136/bjophthalmol-2020-316152
2) Glaucoma and neuroinflammation: an overview
Quaranta L, Bruttini C, Micheletti E, Konstas A.G.P, Michelessi M, Oddone F, Katsanos A, Sbardella D, De Angelis G, Riva I.
Surv Ophthalmol. 2021 Feb 11;S0039-6257(21)00034-5. doi: 10.1016/j.survophthal.2021.02.003
3)What do we really know about the effectiveness of glaucoma interventions: An overview of systematic reviews
Qureshi R, Azuara-Blanco A, Michelessi M, Virgili G, Barbosa Breda J, Cutolo C, Pazos M, Katsanos A, Garhofer G, Kolko M, Prokosch V, Al Rajhi A.A, Lum F, Musch D, Gedde S, Li T
Ophthalmol Glaucoma. 2021 Feb 9;S2589-4196(21)00035-1
4) Endothelial Cell Density after XEN Implant Surgery: Short term Data from the Italian XEN Glaucoma Treatment Registry (XEN-GTR)
Oddone F, Roberti G, Posarelli C, Agnifili L, Mastropasqua L, Carnevale C, Micelli Ferrari T, Pace V, Sacchi M, Cremonesi E, Uva M, Menchini M, Brescia L, Figus M.
J Glaucoma. 2021 Apr 2. doi: 10.1097/IJG.0000000000001840
5) The interplay between lipid and Aβ amyloid homeostasis in Alzheimer’s Disease: risk factors and therapeutic opportunities
García-Viñuales S, Sciacca Michele F M, Lanza V, Santoro A M, Grasso G, Tundo Grazia R, Sbardella D, Coletta M, Grasso G, La Rosa C, Milardi D
Chem Phys Lipids. 2021 May;236:105072. doi: 10.1016/j.chemphyslip.2021.105072.
6) Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Sbardella D, Tundo G R, Coletta M, Manni G, Oddone F
Int J Mol Sci. 2021 May 31;22(11):5891. doi: 10.3390/ijms22115891.
7) Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review
Carnevale C, Riva I, Roberti G, Michelessi M, Tanga, Verticchio Vercellin Alice C, Agnifili L, Manni G, Harris A, Quaranta L, Oddone F
Pharmaceuticals 2021, 14(6), 581; https://doi.org/10.3390/ph14060581
8) Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II
Lemmens S, Rossetti L, Oddone F, Sunaric-Mégevand G, Hommer A, Vandewalle E, Cordeiro M F, McNaught A, Montesano G, Stalmans I.
Eur J Ophthalmol. 2021 Apr 5;11206721211006573. doi: 10.1177/11206721211006573.
9) Visual Field Endpoints Based on Subgroups of Points may be Useful in Glaucoma Clinical Trials – A Study with the Humphrey Field Analyzer and the Compass perimeter
Barkana Y, Leshno A, Stern O, Singer R, Russ H, Oddone F, Lanzetta P, Perdicchi A, Johnson Chris A, Garway-Heath David F, Rossetti L M, Skaat A
J Glaucoma. 2021 Apr 23. doi: 10.1097/IJG.0000000000001856.
10) Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
Vernazza S, Oddone F, Tirendi S, Bassi AM.
Int J Mol Sci. 2021 Jul 27;22(15):7994. doi: 10.3390/ijms22157994.
11) Glaucoma heritability: Molecular mechanisms of disease”
Zukerman R., Harris A., Oddone F., Siesky B., Verticchio Vercellin A., Ciulla T.A.
Genes (Basel). 2021 Jul 27;12(8):1135. doi: 10.3390/genes12081135.
12) Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?
Shin JD., Wolf AT., Harris A., Verticchio Vercellin A., Siesky B., Rowe LW., Packles M., Oddone F.
Acta Ophthalmol. 2021 Aug 6. doi: 10.1111/aos.14982. Online ahead of print.
13) Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?
Stoner A., Harris A., Oddone F., Belamkar A., Verticchio Vercellin AC., Shin J., Januleviciene I., Siesky B.
Br J Ophthalmol. 2021 Aug 25;bjophthalmol-2021-319530. doi: 10.1136/bjophthalmol-2021-319530. Online ahead of print.
14) Efficacy and Safety of PreserFlo ® MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
Quaranta L., Micheletti E., Carassa R., Bruttini C., Fausto R., Katsanos A., Riva I.
Adv Ther. 2021 Aug;38(8):4403-4412. doi: 10.1007/s12325-021-01811-w. Epub 2021 Jul 12
15) Do additional testing locations improve the detection of macular perimetric defects in glaucoma?
Montesano G., McKendrick AM., Turpin A., Brusini P., Oddone F., Fogagnolo P., Perdicchi A., Johnson CA., Lanzetta P., Rossetti LM., Garway-Heath DF., Crabb DP.
Ophthalmology, June, 2021. DOI:https://doi.org/10.1016/j.ophtha.2021.06.012
16) Improving event-based progression analysis in glaucomatous visual fields
Rui C., Montesano G., Crabb DP., Brusini P., Chauhan BC., Rossetti LM., Fogagnolo P., Giraud JM., Fenolland JR., Oddone F.
Sci Rep. 2021 Aug 11;11(1):16353. doi: 10.1038/s41598-021-95877-9.
17)At the cutting edge against cancer: insights into the cross-talk between the immunoproteasome and immune checkpoints. Grazia Raffaella Tundo *, Diego Sbardella, Francesco Oddone, Anna Kucriaeva, Pedro Miguel Lacal, Alexey Belogurov, Grazia Graziani *, Stefano Marini.
Cancers (Basel). 2021 Sep 28;13(19):4852. doi: 10.3390/cancers13194852.
18)Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.
Benvenuto M, Ciuffa S, Focaccetti C, Sbardella D, Fazi S, Scimeca M, Tundo GR, Barillari G, Segni M, Bonanno E, Manzari V, Modesti A, Masuelli L, Coletta M, Bei R.
Sci Rep. 2021 Sep 24;11(1):19051. doi: 10.1038/s41598-021-98450-6.
19)A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension.
Katsanos A, Riva I, Bozkurt B, Holló G, Quaranta L, Oddone F, Irkec M, Dutton GN, Konstas AG.
Expert Opin Drug Saf. 2021 Oct 29;1-15. doi: 10.1080/14740338.2022.1996560
20)A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes.
Quaranta L, Bruttini C, De Angelis G, Montescani S, Ardizzone A, Katsanos A, Carnevale C, Oddone F, Riva I.
J Clin Med. 2021 Oct 12;10(20):4668. doi: 10.3390/jcm10204668
21)An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress.
Vernazza S, Tirendi S, Passalacqua M, Piacente F, Scarfì S, Oddone F (colast), Bassi AM.
Int J Mol Sci. 2021 Nov 9;22(22):12129. doi: 10.3390/ijms222212129.
22)Prevalence Rates and Risk Factors for Primary Open Angle Glaucoma in the Middle East.
Torabi R, Harris A, Siesky B, Zukerman R, Oddone F, Mathew S, Januleviciene I, Vercellin ACV.
J Ophthalmic Vis Res. 2021 Oct 25;16(4):644-656. doi: 10.18502/jovr.v16i4.9755.
